| Fanie Wehmanen, | |
|
240 Mitchell Bridge Rd, Athens, GA 30606-2043 | |
| (706) 612-6995 | |
| (706) 369-6328 |
| Full Name | Fanie Wehmanen |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 240 Mitchell Bridge Rd, Athens, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003438979 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Fanie Wehmanen, 3364 Ridge Manor Way, Dacula, GA 30019-2728 Ph: (561) 859-4172 | Fanie Wehmanen, 240 Mitchell Bridge Rd, Athens, GA 30606-2043 Ph: (706) 612-6995 |
News Archive
Immunotherapy that can be effective against tumors in young, thin mice can be lethal to obese ones, a new study by UC Davis researchers has found. The findings, published online today in The Journal of Experimental Medicine, suggest a possible link between body fat and the risk of toxicity from some types of immunotherapy.
Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a number of biological molecules that are key in blocking viral activity and clearing infection.
BG Medicine, Inc., a U.S.-based life sciences company, announced today that the U.S. Food and Drug Administration has cleared the company's Galectin-3 test for use in conjunction with clinical evaluation as an aid to assess the prognosis of patients diagnosed with chronic heart failure. This marks the first time the FDA has cleared a test to measure galectin-3 blood levels, and is the first novel cardiac test cleared by the FDA in five years.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company's exhibition of its barcoded syringe locking device generated overwhelming interest at the annual Medica 2010 Conference in Dusseldorf Germany, held November 16-19.
An international team of researchers led by a Case Western Reserve University School of Medicine scientist has uncovered a novel mechanism in which a protein-neuregulin 3-controls how key neurotransmitters are released in the brain during schizophrenia.
› Verified 2 days ago
Janet Robison Avant, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9739 | |
Marjorie Spencer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mr. Vito Cortese Jr., RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Mitchell Bridge Rd, Athens, GA 30606 Phone: 855-333-9544 | |
Richard Cereneche, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 195 Miles St, Athens, GA 30601 Phone: 706-542-9700 Fax: 706-227-7249 | |
Mary Donna Hall, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 250 North Ave, Athens, GA 30601 Phone: 706-542-0333 Fax: 706-542-9693 | |
Tiny Stephens, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 675 College Ave, Athens, GA 30601 Phone: 706-546-5526 |